This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.
OUTLINE: OBJECTIVE 1 DEVELOPMENT OF INTERVENTION: Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study. OBJECTIVE 2 PILOT TRIAL: Clinicians attend HOPE-C sessions (changing their narrative, managing life's uncertainty and finding meaning) once weekly for 4 weeks, with each session lasting approximately 30-45 minutes. Clinicians complete a questionnaire before and after completing all HOPE-C sessions. OBJECTIVE 3: Clinicians may undergo an interview after completing HOPE-C sessions.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
25
Complete HOPE-C sessions
Complete interview
Ancillary studies
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
RECRUITINGObjective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C)
Will assess clinician's feedback around the content, delivery structure, and materials for the adapted HOPE-C intervention. Qualitative Description will be used to analyze the data.
Time frame: Day 1
Objective 2: Feasibility (Accrual rate)
Feasibility cutoff includes ≥ 50% of eligible clinicians enrolling in the study.
Time frame: At time of enrollment
Objective 2: Feasibility (Rate of intervention completion)
Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all sessions.
Time frame: At 4 weeks
Objective 2: Feasibility (Rate of survey completion)
Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all surveys.
Time frame: At baseline and 2-week post-intervention
Objective 2: Acceptability of HOPE-C
Assessed by the Theoretical Framework of Acceptability (TFA) questionnaire, which is an 8-item questionnaire assessing acceptability of healthcare interventions across seven constructions: Affective Attitude, Burden, Ethicality, Intervention Coherence, Opportunity Costs, Perceived Effectiveness and Self-efficacy. Items are rated on a 5-point Likert scale (e.g., 1 = strongly dislike, 5 = strongly like) and a mean is computed across all seven constructs (n=7 items) and a single outcome is examined for the general item. Total mean score ranges from 1 to 5, with higher scores indicating greater acceptability of the intervention.
Time frame: At 2-week post-intervention
Objective 2: Satisfaction of HOPE-C
Will be assessed by using three items assessing overall satisfaction. A cutoff score of ≥ 7 (out of 10) will be used for each satisfaction item.
Time frame: At 2-week post-intervention
Objective 3: Optimization of the intervention
Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on how to optimize the intervention in clinical settings.
Time frame: At 2-week post-intervention
Objective 3: Delivery of the intervention
Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on the delivery of the intervention in clinical settings.
Time frame: At 2-week post-intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.